Skip to main content
Industry News
Sanofi buys out Tidal Therapeutics for $470M

Sanofi has acquired Tidal Therapeutics in a deal worth $470 million, with Tidal eligible to receive $160 million as an upfront payment and an additional $310 million for a variety of milestone payments. Tidal is developing nanoparticles to deliver messenger RNA to immune cells for reprogramming against immune diseases and cancer.

Full Story: